Anti-Factor IIa (FIIa) Heparin Assay for Patients on Direct Factor Xa (FXa) Inhibitors.

CONCLUSIONS: The BIOPHEN™ ANTI-IIa assay is suitable for patients transitioning off apixaban or rivaroxaban.
PMID: 32216028 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - March 24, 2020 Category: Hematology Authors: Stuart M, Johnson L, Hanigan S, Pipe SW, Li SH Tags: J Thromb Haemost Source Type: research